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ImagingonSubsequentUtilizationofCoronary
AngiographyandOutcome
N.Nallamothu,R.Dhawan,G.Campbell,E.R.Acio,S.Bala-Gupte,
W. VanDecker, J. Heo, A.E. Iskandrian. Allegheny University of the Health
Sciences, Philadelphia, PA, USA
Previous studies show conflicting results of the impact of exercise SPECT
perfusion imaging on subsequent utilization of invasive procedures. This
study examined the impact of adenosine SPECT thallium imaging in 1365
patients (pts) with chest pain syndromes with no prior coronary revascular-
ization. There were 6S6 men and 779 women aged 67 + 12yrs. The pre-test
probability of CAD was 62 + 29%. The SPECT images were normal in 740
pts (54%) and abnormal in 625 pts (46%). Subsequent coronaty angiography
was performed in 57 pts (7.7’%.)with normal images and in 241 pts (39Yo)with
abnormal images (p c 0.01). Follow-up of up to 3 years was available in 221
pfe (74%) who had coronaty angiography. There were 11hard events (death
or non-fatal myooardial infarction) in pts with abnormal images and in none
with normal images (p < 0.01). There were also 61 coronary revasculariza-
tion procedures in the pts with abnormal images and 5 in the pts with normal
images (p < 0.01). The pts with abnormal images and hard events had more
extensive perfusion defects than those with no events (defect size 22 + 6Y0
vs 17 + 9%, p < 0.05; number of segments with perfusion abnormality 11+
5% VS 6 + 5%, p < 0.05).
Thus, the results of adenosine SPECT perfusion imaging have appropri-
ate impact on subsequent utilization of invasive procedures and outcome
in pte with intermediate pre-test probability of CAD. Coronary angiogrephy,
coronaiy revaecularizetion and cardiac events are infrequent in pts with
normal images.
m109559 AcuteMyocardialParfuaionImagingforChsstPainReducasthe LengthofCardiacWork-up:A
RandomizedTrial
M.D. Duce, R.S. Morris, A.W. Ahlberg, G.M. Cyr, A. Russell, R.K. Sargent,
D. Waters, G.V. Heller. Hartford Hospital, Hartford, CT, USA
Although acute myocardial perfusion imaging (MPI) during chest pain corre-
lates well with stress MPI, its impact upon cost and length of cardiac work-up
(LOCW) has not been assessed. Accordingly, 33 patients admitted with a
moderate or high probability of myocerdial ischemia were randomized to
usual care or acute Tc-99m sestamibi SPECT imaging during or within 2
hours of chest pain. Acute image results were immediately reported to the
attending physician who managed the subsequent work-up. Length of oer-
diac work-up and associated hospital charges were compared between the
2 groups, including a charge for acute MPI.
n LOCWdsy#pt Ptsin ICU Chargee$/pt
Acute MPI 17 2,0* 1.2* 5 3555 + 1396
No MPI 16 3.2 + 1.7 2 3467 + 1S79
lp= 0.02 vs no MPI
Acute MPI significantly reduced the length of cardiac work-up by 1.2
days. In addition, despite more ICU admissions in that group, there was no
significant increase in charges with acute MPI.
Conckrsion:Acute myocerdial perfusion imaging for chest pain in patients
with at least a moderate. probability of myocardial ischemia significantly
reduced the length of cardiac work-up at no added expense.
m109560 Prediotoraof CardiacCatheterizationinaMulticenterRegistryofStableAnginaPatienta
G.V. Heller, L.J. Shaw, K.L. Kesler, A.T. Fossati, R. Hachmanovitch,
T. Marwick, M.S. Lauer, D.S. Berman, S. Borges-Neto, D.D. Miller. Hartford
Hospital, Hardord, CT, USA
Recent studies suggest that a relationship exists between rates of noninva-
sive testing and subsequent cardiac catheterization (CATH).We examined a
multioenter geogrephieslly diverse database of 7,706 stable angina patients
from 7 hospitals (mean age= 64 years, 35% female) for factors predictive of
CATHs 90days after stress myocerdial perfusion imaging (MPI). Thepredic-
tivevalue of clinical history and streee MPI were evaluatad by a risk-adjusted
multivariable logistic regression model predicting CATH (overall CATH rate
= 17%). A clinical risk index was developed based upon each patient’s age,
sex, symptoms, and cardiac risk factor profile. The table indicates the final
multivariable model predicting CATH:
Risk-Adjusted Multivariable Model
Odds Ratio (950/. Cl) DValue
No. Periusion Areas With
lachemia 1.5 (1.4-1.6) <0.00001
Infsrtiion 1,1 (1.1-1 .2) <0.00001
Clinical Risk Index 1.1 (1.C-1.2.) 0.03
Using an incremental chi-square analysie, etrese MPI contributed 92% of
the information in predicting CATH.
Conclusion: The extent and severity of perfueion defects by stress my-
ocerdial perfusion imaging are highly predictive of resource utilization, and
are specifically predictive of subsequent cardiac catheterization.
\ 1095-61 I PharmaCOacOnOmicsOfAdenOsineand
DipyridamoleMyocardialPerfusionImaging
B.D. Lucas, Jr., S.M. Mohiuddin, J. Sekutera, D.E. Hilleman.
WVU-Chadeston Division, Charleston, WV USA, Creighton University
Omaha, NE, USA
Adenosine and dipyridamole are FDA-approved as adjuncts for myooerdial
perfusion imaging (MPI). Repotied CAD detection sensitivities and spaei-
ficities have been largely similar; therefore, making eost-effeetivenesa dom-
inant in drug selection. We conducted a pharmacoeconomic analysie of IV
adenosine and IV dipyridamole use in MPI. The design was a cese-cantrol,
cost-minimization analysis (direct cost accounting approach estimating insti-
tutional costs). A 2:1 (adenosine:dipyridamole; n = 166:n = 83) match based
on age, gender, weight, prior Ml and prior corona~ revascularization was
ueed. Consecutive patients unable to perform adequate exercise referred for
MPI to evaluate CAD were included. Agents were administered according to
FDA-approvad manufacturer recommendations. The setting waa a university
hospital nuclear medicine depaflment. Costs included drug acquisition, ad-
ministration, monitoring, adverse event treatment, follow-up care and repeat
tests. Although adenosine had a greater acquisition cost than dipyridamoie,
the remaining four costs were significantly less (p < 0.001). The frequency
of adverse events was not significantly different between adenosine and
dipyridamole. However, adverse events requiring intervention were greater
for dipyridamole (24% vs 5%, p < 0.001). Indeed, dipyridamole had a signifi-
cantly greater number of adverse eVentS persisting ? 10 min (29% vs 0.6%)
and occurring late-onset (p < 0.001). Consequently, the total cost per patient
was significantly less for adenosine ($379.0 + 131.9 va $4S3.1 + 224.2, p c
0.001). Despite a higher acquisition cost, adenosine was more cost-effective
than dipyridamole in conjunction with MPI. Adenoeine mst was less because
of lower administration, monitoring, adverse event, repeat teet and follow-up
care costs.
-[ DoesAge,nCreaseDia9nosticand~o,lo~-uP
CostofStableAnainaPatients?A Multicanter-——.
ClinicalStudy.of~491 PatientsWithperfusion
ImagingandCoronaryAngiography
S. Borges-Neto, M, Travin, L.J. Shaw, K, Kesler, D. Berman,
R, Hachamovitch, G.V. Heller, T. Marwick, D.D. Miller for the END
Investigators Group. Duke University Medical Center, Durham, NC, USA
The influence of advanced age on cost efficient resource use has not been
investigated in a large eeries of stable angina patients. We followed 9,491
symptomatic patients for 3 years who underwent stress perfueion imaging
at 6 tertia~ referral centers. We compar6d diagnostic and follow-up cost in
elderly (age 2 65) versus non-elderly (age c 65) patients by analysis of
variance. Cost was calculated by Medicare hospital (adjusted by cost charge
ratio) and physician billing date. A similar total cost was obsemd for elderly
and non-elderfy patients; however, high pretest risk (probability ? 0.60)
elderly patients had a significantly lower diagnostic and follow-up cost than
non-elderly high risk patients despite a higher mortality rate in the elderly (3.0
vs. 1.3%, p c 0.001). Subsequent revascularization was eimilar in elderly ve.
non-elderly (4.7 vs. 5.39!.,p =-0.20); however, more elderly patients I’eCSivWl
subsequent medical therapy without diagnostic catheterization (49 vs 66%,
p < 0.05).
Conclusion: 1) Underutilization of diagnostic and follow-up resource use
is obsewed through 3 yeara of follow-up in elderly patients despita a higher
modality rate, and 2) Younger patients have a more aggressive, but costly
management course. Reassessment of diagnostic and follow-up strategies
should be considered for stable angina elderly patients.
